The role of atherectomy in the treatment of lower extremity peripheral artery disease

被引：42

作者：

Franzone, Anna ^{[1
]}

Ferrone, Marco ^{[1
]}

Carotenuto, Giuseppe ^{[1
]}

Carbone, Andreina ^{[1
]}

Scudiero, Laura ^{[1
]}

Serino, Federica ^{[1
]}

Scudiero, Fernando ^{[1
]}

Izzo, Raffaele ^{[1
]}

Piccolo, Raffaele ^{[1
]}

Saviano, Savio ^{[1
]}

Amato, Bruno ^{[2
]}

Perrino, Cinzia ^{[1
]}

Trimarco, Bruno ^{[1
]}

Esposito, Giovanni ^{[1
]}

机构：

[1] Univ Naples Federico II, Dept Clin Med Cardiovasc & Immunol Sci, I-80131 Naples, Italy

[2] Univ Naples Federico II, Dept Gen Geriatr Oncol Surg & Adv Technol, I-80131 Naples, Italy

来源：

BMC SURGERY | 2012年 / 12卷

关键词：

MUSCLE-CELL-PROLIFERATION; ORBITAL ATHERECTOMY; EMBOLIC PROTECTION; IN-VIVO; ASPIRATION ATHERECTOMY; OCCLUSIVE DISEASE; VASCULAR INJURY; CLINICAL IMPACT; ABDOMINAL-AORTA; ANGIOPLASTY;

D O I：

10.1186/1471-2482-12-S1-S13

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: The incidence of lower extremity peripheral artery disease (LE-PAD) continues to increase and associated morbidity remains high. Despite the significant development of percutaneous revascularization strategies, over the past decade, LE-PAD still represents a unique challenge for interventional cardiologists and vascular surgeons. Method: Typical features of atherosclerosis that affects peripheral vascular bed (diffuse nature, poor distal runoff, critical limb ischemia, chronic total occlusion) contribute to the disappointing results of traditional percutaneous transluminal angioplasty (PTA). New technologies have been developed in attempt to improve the safety and effectiveness of percutaneous revascularization. Among these, atherectomy, debulking and removing atherosclerotic plaque, offers the potential advantage of eliminating stretch on arterial walls and reducing rates of restenosis. Conclusions: This review summarizes the features and the current applications of new debulking devices.

引用

页数：9

共 56 条

[1] Optimal Techniques with the Diamondback 360° System Achieve Effective Results for the Treatment of Peripheral Arterial Disease [J].